Posted by Michael Wonder on 10 Apr 2024
Why won’t health insurance companies pay for new drugs?
10 April 2024 - The FDA is doing its part to fast-track new treatments, but insurers are standing in the way of affordable access.
On 6 January 2023, the FDA granted accelerated approval for a new treatment for Alzheimer’s: Leqembi, a drug that may slow the disease’s progression.
And yet mere hours after its approval, the Centers for Medicare & Medicaid Services, the largest insurer in the country, announced that it would not cover the drug for Medicare patients.
